Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 11/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1611553 | 0.95 | KDM4E (0.45) | KDM4EALDH1A1GAAGABRA1GABRB2 | |
| SCHEMBL1610986 | 0.94 | ALDH1A1 (0.44) | KDM4EALDH1A1GAAGABRA1GABRB2 | |
| SCHEMBL1611895 | 0.92 | KDM4E (0.50) | KDM4EALDH1A1GAAGABRA1GABRB2 | |
| SCHEMBL1611135 | 0.85 | CNR2 (0.47) | KDM4EALDH1A1CNR2LMNACNR1 | |
| SCHEMBL1610203 | 0.83 | ALDH1A1 (0.51) | KDM4EALDH1A1GAAGABRA1GABRB2 | |
| SCHEMBL28879919 | 0.81 | ALDH1A1 (0.54) | KDM4EALDH1A1GAAGABRA1GABRB2 | |
| SCHEMBL1610685 | 0.81 | CNR2 (0.48) | KDM4EALDH1A1CNR2LMNACNR1 | |
| SCHEMBL1612234 | 0.79 | CNR2 (0.49) | CNR2CNR1CYP2C9 | |
| SCHEMBL1611743 | 0.76 | MEN1 (0.47) | KDM4EALDH1A1CNR2LMNACNR1 | |
| SCHEMBL21834972 | 0.76 | ALDH1A1 (0.51) | KDM4EALDH1A1GAAGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | KDM4E 1272/4885ALDH1A1 137/4885GAA 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.